<DOC>
	<DOCNO>NCT00143208</DOCNO>
	<brief_summary>This study design open label evaluation efficacy latanoprost timolol fix combination ( Xalacom ) 6 month treatment . Eligible patient may enrol baseline visit . All current ocular hypotensive therapy must discontinue time . On baseline day , patient eligible study receive Xalacom instill morning .</brief_summary>
	<brief_title>Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh .</brief_title>
	<detailed_description />
	<mesh_term>Ocular Hypertension</mesh_term>
	<criteria>Diagnosis glaucoma ( primary open angle , pigmentary , exfoliative ) ocular hypertension ( IOP &gt; = 21 mmHG ) . Visual acuity &gt; = 20/200 . Closed/barely open anterior chamber angle history acute angle closure glaucoma . Hystory ALT within 3 month prior baseline visit . History ocular filter surgical intervention . Ocular surgery inflammation/infection within 3 month prior baseline visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>